Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nobuo Morikawa"'
Autor:
Nobuo, Morikawa
Publikováno v:
修道商学. 50(2):307-325
Publikováno v:
Pharmaceutical Research. 19:108-111
Autor:
Nobuo, Morikawa
Publikováno v:
修道商学. 41(1):375-392
Autor:
Nobuo Morikawa
Publikováno v:
Asian Business & Management. 5:449-451
Publikováno v:
Clinical and Experimental Immunology. 96:230-237
SUMMARYA quantitative and qualitative change in inflammatory cells in the lungs of mice after intratracheal inoculation of heat-killed Cryptococcus neoformans was examined by direct analysis of the pulmonary intraparenchymal leucocytes. Macrophages a
Autor:
Nobuo, Morikawa
Publikováno v:
松山大学論集 = Matsuyama University review. 5(4):85-107
Autor:
Shiro KUSANO, Hiroshi MUKAE, Tohru MORIKAWA, Tsunehiko ASAI, Hideaki SAWA, Nobuo MORIKAWA, Hiroshige ODA, Osamu SAKITO, Chieko SHUKUWA, Reiko SENJU, Kazuyoshi KAWAKAMI, Kiyoyasu FUKUSHIMA, Jun-ichi KADOTA, Shigeru KOHNO, Kohei HARA
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 67:7-11
The mechanisms of erythromycin (EM) in chronic lower respiratory tract diseases including diffuse panbronchiolitis (DPB) has been reported. In this study we investigated the effect of EM on peripheral neutrophil adhesion molecules such as LFA-1 and M
Autor:
Nobuo Morikawa, Hidehito Matsuoka, Hajime Ibuki, Masato Horiuchi, Hidefumi Yamaguchi, Hideo Takashina, Syogo Miyagi
Publikováno v:
Drug Metabolism and Pharmacokinetics. 7:315-330
The absorption, distribution, metabolism and excretion of 14C-semotiadil fumarate (14C-SD3211) were studied in rats after oral (dose ; 10mg/kg) or intravenous (1 mg/kg) single administration. 1. Concentration of radioactivity in the plasma reached th
Autor:
Senju R, Tsunehiko Asai, Kiyokazu Komori, Jun-ichi Kadota, S. Kawamoto, Kohei Hara, Hiroshi Mukae, Hiroshige Oda, Chieko Shukuwa, Shiro Kusano, M. Kaseda, Hideaki Sawa, Nobuo Morikawa, Kazuhito Hiratani, Osamu Sakito, Atsushi Yokoyama, Toru Morikawa, Kiyoyasu Fukushima, Masaki Hirota, Shigeru Kohno
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 66:194-200
Recently, "low dose and long term" erythromycin (EM) treatment has been reported as effective on chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB). However the effective mechanism of EM is still obscure. In this study,
Autor:
Hiroshige ODA, Jun-ichi KADOTA, Osamu SAKITO, Hiroshi MUKAE, Nobuo MORIKAWA, Chieko SHUKUWA, Reiko SENJU, Hideaki SAWA, Shiro KUSANO, Tohru MORIKAWA, Tsunehiko ASAI, Kiyoyasu FUKUSHIMA, Kiyotaka KOMORI, Shigeru KOHNO, Kohei HARA, Kazuhito HIRATANI, Masaki HIROTA
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 66:441-447
It is well known that erythromycin (EM) therapy is effective on chronic lower respiratory tract disease, including diffuse panbronchiolitis (DPB). In this study we investigated the relationship between clinical findings and neutrophil chemotactic act